Clinical and epidemiological features of patients with chronic hepatitis C co-infected with HIV

Eduardo Lorens Braga1, André Castro Lyra, Fabrizio Ney-Oliveira

  • 1Department of Medicine, Gastro-Hepatology Service, Federal University of Bahia, Salvador, BA, Brazil. elbraga@ig.com.br

Insights

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection worsens chronic hepatitis C. Co-infected patients showed more severe liver disease and higher rates of genotype-2/3, emphasizing the need for Hepatitis B virus (HBV) immunization.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection is a growing global health concern.
  • Antiretroviral therapy has increased HIV-positive individuals' lifespan, potentially accelerating HCV-related liver disease progression.
  • Understanding the interplay between HCV and HIV is crucial for managing chronic hepatitis C in co-infected populations.

Purpose of the Study:

  • To investigate the clinical and epidemiological characteristics of patients with chronic hepatitis C co-infected with HIV.
  • To analyze the impact of HIV co-infection on the progression of HCV-induced liver disease.
  • To identify risk factors and specific HCV genotypes associated with co-infection.

Main Methods:

  • A comparative study involving 134 HCV-infected patients, divided into 65 co-infected (HCV/HIV) and 69 mono-infected (HCV) groups.
  • Assessment of liver disease severity using Child's score, ultrasound, and liver histology.
  • HCV genotyping and anti-HBs (hepatitis B surface antibody) levels were determined for all participants.

Main Results:

  • Co-infected patients exhibited a higher prevalence of severe liver disease (Child's score B or C) and ultrasound-diagnosed chronic liver disease.
  • Injected drug use and homo/bisexual practices were significantly more common in the co-infected group.
  • HCV genotypes 2/3 were more frequently observed in patients with HCV/HIV co-infection.

Conclusions:

  • HIV co-infection appears to negatively influence the clinical progression of chronic hepatitis C.
  • Specific risk factors like injected drug use and sexual practices, along with HCV genotype 2/3, are more prevalent in co-infected individuals.
  • Routine immunization against Hepatitis B virus (HBV) is strongly recommended for patients with HCV/HIV co-infection.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...